Literature DB >> 1634685

Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries.

J K Williams1, M R Adams, D M Herrington, T B Clarkson.   

Abstract

OBJECTIVES: This experiment sought to determine the effect of short-term administration of estrogen on endothelium-dependent dilation in the coronary arteries of 13 surgically postmenopausal female cynomolgus monkeys.
BACKGROUND: Long-term estrogen replacement therapy prevents impaired endothelium-dependent dilation of atherosclerotic coronary arteries in postmenopausal female monkeys. However, it remains unclear whether this action of estrogen is due to long-term effects on plasma lipids and atherogenesis or to direct short-term effects on the endothelium.
METHODS: The monkeys consumed an atherogenic diet for 18 months after bilateral ovariectomy. Vascular responses were measured just before euthanasia and necropsy. Dextrose in water (control), acetylcholine, 10(-6)M, and nitroglycerin were infused for 2.5 min each both before and 20 min after intravenous injection of 54 ng ethinyl estradiol.
RESULTS: Quantitative coronary angiography revealed that the arteries constricted (-17 +/- 3%) in response to intracoronary infusion of acetylcholine before estrogen treatment but dilated (+5 +/- 3%) 20 min after intravenous injection of ethinyl estradiol (p less than 0.05). Coronary arteries dilated in response to nitroglycerin both before and after administration of estrogen (p greater than 0.05). Vascular responses of coronary arteries, both before and after administration of estrogen, were not associated with variation in plasma lipid concentrations, blood pressure, heart rate or plaque size.
CONCLUSIONS: Estrogen affects endothelium-dependent coronary dilation within 20 min of administration and may have rapid direct effects on the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634685     DOI: 10.1016/0735-1097(92)90116-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  26 in total

1.  Enhanced relaxation of porcine coronary arteries after acute exposure to a physiological level of 17beta-estradiol involves non-genomic mechanisms and the cyclic AMP cascade.

Authors:  H Teoh; R Y Man
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 2.  Gonadal hormone substitutes: effects on the cardiovascular system.

Authors:  T B Clarkson; J M Cline; J K Williams; M S Anthony
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits.

Authors:  P Holm; N Korsgaard; M Shalmi; H L Andersen; P Hougaard; S O Skouby; S Stender
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 4.  Hormone replacement therapy and heart disease: the remains of the oestrogen hypothesis.

Authors:  A H E M Maas; Y T van der Schouw; D E Grobbee; Y van der Graaf
Journal:  Neth Heart J       Date:  2003-11       Impact factor: 2.380

Review 5.  Hormone replacement therapy in the aged. A state of the art review.

Authors:  S Jacobs; T C Hillard
Journal:  Drugs Aging       Date:  1996-03       Impact factor: 3.923

6.  Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease.

Authors:  Svati H. Shah; Karen P. Alexander
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-02

7.  Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice.

Authors:  R H Karas; J B Hodgin; M Kwoun; J H Krege; M Aronovitz; W Mackey; J A Gustafsson; K S Korach; O Smithies; M E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

8.  Investigation of the negative inotropic effects of 17 beta-oestradiol in human isolated myocardial tissues.

Authors:  G Sitzler; O Lenz; H Kilter; K La Rosee; M Böhm
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

9.  Implications of plasma concentrations of adiponectin in patients with coronary artery disease.

Authors:  Y Nakamura; K Shimada; D Fukuda; Y Shimada; S Ehara; M Hirose; T Kataoka; K Kamimori; S Shimodozono; Y Kobayashi; M Yoshiyama; K Takeuchi; J Yoshikawa
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

10.  Estrogen inhibits the response-to-injury in a mouse carotid artery model.

Authors:  T R Sullivan; R H Karas; M Aronovitz; G T Faller; J P Ziar; J J Smith; T F O'Donnell; M E Mendelsohn
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.